Apple will let 200,000 people ask a chatbot about their own heart rate and lab results, to find out whether right answers actually help
Apple has launched the Apple Health AI Usage Study, a US research project in which up to 200,000 adults can ask an AI chatbot everyday health questions and, if they choose, let it see their own iPhone health data. The chatbot is built with clinical AI company OpenEvidence, and Apple says none of the study data will train AI models. Apple says the research will inform future products. It is not open to Australians.
Three things to know
- The study is open to US adults aged 21 and over with an iPhone 15 Pro or later running iOS 26, through a dedicated study app.
- Participants can share resting heart rate, activity, sleep and lab results so answers can be tailored, and every answer links to peer-reviewed clinical sources.
- Apple says study data will not be used to train AI models, and OpenEvidence will delete questions and answers within 24 hours.
Apple has opened a study that asks a question most AI companies skip: not whether a chatbot gets health answers right, but whether ordinary people can understand and use them.
The Apple Health AI Usage Study, announced on Sunday US time, will enrol up to 200,000 adults across the United States. Participants download a study app, go through an informed consent process and then ask everyday health questions. Answers come in plain language with links to peer-reviewed clinical citations.
The answers are generated with OpenEvidence, a clinical AI platform used by health professionals that draws on medical journals. Full access to OpenEvidence is otherwise limited to health care workers.
What makes it different from asking any chatbot?
Your own data. Participants can choose to share HealthKit information such as resting heart rate, activity, sleep and lab results, so the chatbot can tailor its answer. Someone asking how to bring down their resting heart rate, for example, could get advice based on their own measurements.
The app also offers summaries to help people prepare for appointments with their own doctor, and has guardrails meant to detect certain concerning questions and point the user to a health provider or other help. Apple says the app does not diagnose or treat any condition and does not replace medical advice.
Sumbul Desai, Apple’s vice-president of health and fitness, said “responsible innovation starts with scientific rigor and clinical grounding.”
What happens to the data?
Apple says the study was designed with privacy protections from the start and that study data will not be used to train AI models. Participants decide whether to share health metrics or survey responses. Questions are stripped of identifying information before they reach OpenEvidence, which will delete question-and-response data within 24 hours and will not train its model on the queries.
Participants rate answers and fill in occasional surveys. Apple has said the research will inform future products and that it plans to make the findings broadly available.
Why does usability matter so much?
Because the gap is large. A study published in Nature Medicine in February found AI chatbots identified medical conditions in clinical cases nearly 95% of the time, but everyday users trying to work through dense guidance reached the right answer less than 35% of the time.
Apple itself acknowledges that consumer health tools built on large language models can give answers that are incomplete or unclear. The study is designed to find out where that breaks down for real people with real data.
Can Australians join?
No. The study is limited to the United States, and Apple has said nothing about running it, or releasing any resulting feature, elsewhere.
The timing is pointed for Australian readers. A Lowy Institute poll released on Sunday found 65% of Australians think AI does more harm than good. Health is where that trust question becomes personal: a chatbot reading your lab results is a very different proposition from one drafting an email.
What would change things?
Apple has said the findings will inform future products. If the study shows people understand and act sensibly on tailored answers, that is evidence for building such a feature into its products. If it shows confusion or risky behaviour, it gives Apple, regulators and doctors hard evidence on where the limits should be.
How we got here
The key moments that brought this story into focus. Open any moment for detail.
February 2026Usability gap measured
A Nature Medicine study finds everyday users get far worse results from health chatbots than the chatbots do alone.
15 November 2026Study launched
Apple and OpenEvidence open the Apple Health AI Usage Study to up to 200,000 US adults.
What happens next
Enrolment is open now in the US through the study app. Apple has not said how long the study will run or when results will be published, only that it intends to share the research broadly.
Sources
- VNN
VNN never names people who give us information in confidence. How we protect sources and tips.
That is the story in a minute. For the evidence, context and what happens next, switch to the full story.
Weather today
Monday 16 November
Perth
Warm under grey skies · 10% rain
27°16°
A warm, grey Monday for Perth; heavy showers soak Brisbane and Singapore, Paris stays wet and London wakes cold but bright.
- Sydney18°15°
- Melbourne14°9°
- Brisbane28°20°
- Adelaide19°10°
- Auckland21°15°
- Singapore28°25°
More cities (13)
- Tokyo18°13°
- Hong Kong26°20°
- Mumbai32°23°
- Dubai30°20°
- Nairobi24°16°
- Lagos31°26°
- Johannesburg27°15°
- London7°4°
- Paris11°10°
- New York10°4°
- Los Angeles20°16°
- Toronto9°4°
- Sao Paulo25°19°
Highs and lows in °C, local time.
Breaking now
Live deskDeveloping stories
Live deskMost read this week
For subscribers
Read every subscriber story in full, on any device. Premium reports are sold separately.
Secure payment · Cancel anytime · Subscribers sign in
Markets
Stocks
- Alphabet (GOOGL)Nasdaq295.77 USDdown -0.98%
- Amazon (AMZN)Nasdaq266.66 USDdown -0.29%
- Apple (AAPL)Nasdaq356.27 USDup +0.39%
- ASX 200ASX9,082.20down -0.71%
- Berkshire Hathaway (BRK.B)NYSE592.94 USDup +0.53%
- BHP Group (BHP)ASX58.86 AUDdown -1.26%
Currencies
- AUD/EURForex0.613500 EURdown -0.29%
- AUD/GBPForex0.511800 GBPdown -0.47%
- AUD/JPYForex107.8800 JPYdown -0.85%
- AUD/NZDForex1.224200 NZDdown -0.25%
- AUD/USDForex0.675900 USDdown -0.66%
- BTC/USDCrypto68,241.00 USDdown -4.59%
As at 14 Nov 2026, 5:52 am GMT+0800. Entered by VNN. Not financial advice.
For you
Follow the topics you care about and save stories with the bookmark. They gather here, on this device only.
Saved on this device only. Nothing is sent to VNN.
Help keep the lights on.
Independent news costs money to make and nothing to read. Chip in and keep it that way.
ContributeFrom A$5 a month · Cancel anytimeThe daily briefing
Start informed.
The essential headlines, the useful context and what to watch next, in your inbox each morning.







Comments
0 commentsCommunity rules
To read and join the conversation, please agree to our rules.
You have agreed to the community rules.
No comments yet. Start the conversation.